Neurology
Found 8 results
Filters: Keyword is Parkinson Disease  [Clear All Filters]
2020
Parmar M, Grealish S, Henchcliffe C.  2020.  The future of stem cell therapies for Parkinson disease.. Nat Rev Neurosci. 21(2):103-115.
2019
Kang Y, Henchcliffe C, Verma A, Vallabhajosula S, He B, Kothari PJ, Pryor KO, P Mozley D.  2019.  18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease.. J Neuroimaging. 29(1):97-103.
Kummer BR, Diaz I, Wu X, Aaroe AE, Chen ML, Iadecola C, Kamel H, Navi BB.  2019.  Associations between cerebrovascular risk factors and parkinson disease.. Ann Neurol. 86(4):572-581.
Seifan A, Ganzer CA, Ryon K, Lin M, Mahmudur R, Adolfo H, Shih C, Jacobs AR, Greenwald M, Isaacson RS.  2019.  Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases.. Curr Aging Sci. 11(4):242-249.
Cabrera LY, Sarva H, Sidiropoulos C.  2019.  Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians.. World Neurosurg. 128:e16-e20.
Rana AQayyum, Qureshi ARehman, Siddiqui O, Sarfraz Z, Rana R, Shtilbans A.  2019.  Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.. J Neurol. 266(9):2093-2102.
2018
Kang Y, P Mozley D, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J et al..  2018.  Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.. J Neuroimaging. 28(5):496-505.
Barone DA, Henchcliffe C.  2018.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.. Clin Neurophysiol. 129(8):1551-1564.